Cardiovascular Disorders
Clinical research activity includes hypertension linked with obesity, with interest in treatment strategies for resistant hypertension and related cardiometabolic risk.
- Blood pressure control
- Obesity management
- Cardiometabolic disease
Work in this area focuses on interventions aimed at improving cardiovascular outcomes in people with complex, treatment-resistant disease.
Substance Use Disorders
The sponsor supports research in cocaine use disorder, including powder and intranasal cocaine dependence, within a psychiatric and addiction medicine context.
- Addiction treatment
- Cocaine dependence
- Psychological support
This area reflects interest in therapies for substance-related conditions where behavioural and pharmacological support are both clinically relevant.
Psychiatric and Neurological Therapies
Research activity also extends to psilocybin-based treatment approaches for mental health and addiction-related conditions, with attention to supportive care alongside active therapy.
- Psilocybin
- Psychological support
- Controlled pilot studies
The therapeutic focus includes exploration of novel options for disorders where standard approaches may have limited effectiveness.
Clinical Feasibility and Translational Research
The portfolio is concentrated on feasibility and pilot clinical trials designed to inform later-stage investigation in both cardiovascular and addiction medicine.
- Multicentre trial activity
- Randomised controlled studies
- Translational clinical research
These studies are positioned to support development of future interventional research in targeted therapeutic areas.
